Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AcelRx PharmaceuticalsStrongbridge BiopharmaSavaraCymaBay TherapeuticsGalectin Therapeutics
SymbolNASDAQ:ACRXNASDAQ:SBBPNASDAQ:SVRANASDAQ:CBAYNASDAQ:GALT
Price Information
Current Price$1.29$3.36$2.43$3.89$2.86
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.31.51.61.72.0
Analysis Score3.33.53.34.53.5
Community Score2.72.32.42.92.7
Dividend Score0.00.00.00.00.0
Ownership Score0.01.01.01.04.0
Earnings & Valuation Score0.60.61.30.00.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$5.67$9.88$8.32$9.09$6.50
% Upside from Price Target339.28% upside193.90% upside242.39% upside133.70% upside127.27% upside
Trade Information
Market Cap$104.18 million$183.90 million$126.82 million$267.95 million$163.10 million
Beta1.761.590.921.492.5
Average Volume1,158,808384,971317,4907,720,070232,117
Sales & Book Value
Annual Revenue$2.29 million$21.71 millionN/A$10 millionN/A
Price / Sales45.498.40N/A26.79N/A
CashflowN/AN/A$5.06 per shareN/AN/A
Price / CashN/AN/A0.48N/AN/A
Book Value($0.52) per share$1.33 per share$2.47 per share$2.71 per share$0.76 per share
Price / Book-2.482.53N/A1.44N/A
Profitability
Net Income$-53,240,000.00$-49,450,000.00$-78,170,000.00$-102,810,000.00$-13,290,000.00
EPS($0.67)($1.10)$4.57($1.46)($0.39)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-2,302.53%-181.82%N/AN/AN/A
Return on Equity (ROE)N/A-57.46%-53.48%-43.33%-32.09%
Return on Assets (ROA)-57.09%-36.67%-40.16%-39.90%-29.49%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.28%0.01%N/A
Current Ratio3.69%2.86%13.90%15.60%33.35%
Quick Ratio3.50%2.80%13.90%15.60%33.35%
Ownership Information
Institutional Ownership Percentage23.12%47.56%46.02%85.11%18.40%
Insider Ownership Percentage7.50%6.60%4.77%4.00%40.70%
Miscellaneous
Employees6171N/A436
Shares Outstanding80.76 million54.25 million52.19 million68.88 million57.03 million
Next Earnings Date8/3/2020 (Estimated)7/29/2020 (Estimated)8/13/2020 (Estimated)8/5/2020 (Estimated)8/14/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.